 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Apollo Endosurgery (NASDAQ:APEN Get Rating) and Pulse Biosciences (NASDAQ:PLSE Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, dividends, ...

Apollo Endosurgery (NASDAQ:APEN) versus Pulse Biosciences (NASDAQ:PLSE) Head to Head Contrast

This price move could be a signal that APEN may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Apollo Endosurgery (APEN, $10) price may drop as it broke higher Bollinger Band on Apr 03, 2023

This is a Bullish indicator signaling APEN's price could rise from here. Traders may explore going long the stock or buying call options...

Apollo Endosurgery (APEN, $10) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 3, 2023

This is a signal that APEN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Apollo Endosurgery (APEN, $10) RSI Indicator left the overbought zone on April 03, 2023

Morris Financial Concepts Inc. acquired a new position in Apollo Endosurgery, Inc. (NASDAQ:APEN  Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 11,149 shares of the biotechnology companys stock, valued at ...

Morris Financial Concepts Inc. Invests $111,000 in Apollo Endosurgery, Inc. (NASDAQ:APEN)

This price move could indicate a change in the trend, and may be a sell signal for investors...

Apollo Endosurgery (APEN, $9.89) price exceeded its 50-day Moving Average on March 22, 2023

This price move could indicate a change in the trend, and may be a buy signal for investors...

Apollo Endosurgery (APEN, $9.94) price moved above its 50-day Moving Average on March 20, 2023

Apollo Endosurgery, Inc. (NASDAQ:APEN Get Rating) was the recipient of a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 618,900 shares, an increase of 9.3% from the February 13th total of 566,200 shares. Based on an average daily ...

Short Interest in Apollo Endosurgery, Inc. (NASDAQ:APEN) Increases By 9.3%

This is a signal that APEN's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Apollo Endosurgery (APEN, $9.92) Stochastic Oscillator left the oversold zone on March 16, 2023

Apollo Endosurgery (APEN, $9.87) price exceeded its 50-day Moving Average on March 13, 2023

Apollo Endosurgery develops medical devices for the diagnosis and treatment of gastrointestinal diseases. The company’s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo’s products include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon. Apollo Endosurgery was founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.)  Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled in 1998 (Timeline) with the goal to advance the new discipline; their specific focus was the use of long, flexible instruments deployed through a natural orifice in order to diagnose and potentially treat gastrointestinal disorders.

Watchers	1,712
52-Wk Low	$3.49
52-Wk High	$10.30

Market Cap	$475.49M
Volume (M)	1.66M
52-Wk High	$10.30
52-Wk Low	$3.49

Current Price	$10.00
Prev Close	$9.92
Open	$9.93
Dividend Yield	0.00%
50-Day Moving Average	$9.92
Beta	0.81
Avg. Volume	930,404.00
PE Ratio	-10.21

52-Week High	$10.30
52-Week Low	$3.49
Market Capitalization	$475.49M
EPS	-$0.9791
Price to Book	12.88
Revenue Per Employee	$273,508.90
Enterprise Value/EBITDA	-16.78

APEN Apollo Endosurgery Inc

About

Feed

News

Fundamentals